SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-20-000002
Filing Date
2020-01-08
Accepted
2020-01-08 16:56:14
Documents
1
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157852055684025.html 4  
1 FORM 4 wf-form4_157852055684025.xml 4 3526
  Complete submission text file 0001640455-20-000002.txt   4883
Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Higgons John Duncan (Reporting) CIK: 0001581954 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 20516185

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)